3 Year return

15.32%
20222022Jul '22Jul '2220232023Jul '23Jul '2320242024
Launched on January 2013 (12 years)

Investment Details

₹100

Minimum SIP Amount

₹5000

Minimum one time investment

Fund has no lock-in period

Calculate Returns

Based on past performance of this fund

ENTER AMOUNT

Your Investment ₹3,600
Gain
  • 27.56%
  • ₹992
  • Total Value
  • ₹4,592

Risk Involved

scale

Your principal will be at

Very High Risk

Scheme Information

Asset Under Management

₹7132.82 Cr.

Expense Ratio

0.92% (inclusive of GST)

Exit Load

1% if redeemed or switchd out on or efore completion of 1 Months from the date of allotment of units. NIl if redeemed or switched out after the completion of 1 Months from the date of allotment of units.

Ratings

ARQ Rating
0

Ratings by other agencies

0
0
0

Tax Implications

Withdrawal within 1 year

Exit load + 15% tax on gains

Withdrawal after 1 year

10% tax on gains over ₹1 Lakh per financial year

Fund Holdings

Holdings
₹7132.82Crores
Other Holdings% of Asset
Dr Reddy's Labs4.78 %
Gland Pharma4.08 %
TREPS3.92 %
J B Chem & Pharm3.7 %
Zydus Lifesci.3.61 %
Abbott India3.2 %
Vijaya Diagnost.3.1 %
Ajanta Pharma3.01 %
Medplus Health3.01 %
Mankind Pharma2.99 %
Aurobindo Pharma2.91 %
Sanofi India2.75 %
Narayana Hrudaya2.71 %
Alkem Lab2.56 %
Glaxosmi. Pharma2.5 %
Torrent Pharma.2.24 %
Pfizer1.9 %
Fortis Health.1.72 %
Thyrocare Tech.1.6 %
Orchid Pharma1.09 %
Syngene Intl.1.09 %
Indoco Remedies0.84 %
Concord Biotech0.59 %
Metropolis Healt0.53 %
Astrazeneca Phar0.48 %
Health.Global0.21 %
Jubilant Pharmo0.07 %
C C I0.02 %
Net CA & Others-0.11 %

Nippon India Mutual Fund Managers

SB

Sailesh Raj Bhan

Fund Manager since May 2018

View Details

Fund House Details

Nippon India Mutual Fund

Nippon India Mutual Fund Asset management company

AUM ₹433,896.92 Cr.
No. of Schemes 293
Setup Date June 1995

Peer Comparison

Comparison with other similar funds

Schemes by Nippon India Mutual Fund

List of mutual fund schemes by AMC

About Nippon India Pharma Fund Direct Plan IDCW Payout

Nippon India Pharma Fund Direct Plan IDCW Payout is an open-ended fund offered by Nippon India Mutual Funds. This is a thematic fund. Nippon India Pharma Fund Direct Plan IDCW Payout is a mutual fund that invests in a diversified portfolio of pharmaceutical companies. The fund aims to generate long-term capital appreciation by investing in companies that are involved in the development, manufacturing, and distribution of pharmaceuticals. It’s an IDCW fund, meaning the fund will distribute a portion of its net income to its investors.

Investment Objectives of the Scheme

The investment objective of the Nippon India Pharma Fund Direct Plan IDCW Payout is to generate long-term capital from investing in a portfolio of pharmaceutical companies' stocks. The fund also aims to provide investors with regular income from their investments. The ideal holding period is 5 years or more.

Key Features of The Fund

5-year return 25.54%
Expense Ratio 0.92%
Fund Manager Sailesh Raj Bhan
Fund Size ₹7132.82 Cr
Risk Profile Very High

Is This Scheme Right for Me?

Nippon India Pharma Fund Direct Plan IDCW Payout is a good option for investors who are looking for a long-term investment that can generate capital appreciation and provide them with regular income. The fund is also a good option for investors who are willing to take on some risk in exchange for the potential for higher returns.

AMC Contact Details

Name Nippon India Mutual Fund
Launch Date June 1995
Addresss Nippon Life India Asset Management Limited, 4th Floor, Tower A, Peninsula Business Park, Ganapatrao Kadam Marg, Lower Parel (W), Mumbai – 400 013
Contact 1860 266 0111
Email customercare@nipponindiaim.in
Website https://mf.nipponindiaim.com/

Disclaimer: Mutual funds are subject to market risk. Read all scheme-related documents carefully to make informed-decision.

Fast-Track Your Short-Term Goals With SIPs

Need funds for that urgent purchase or dream vacation? Use our SIP calculator to fast-track your goals. From building an emergency fund to splurging on a well-deserved break, SIPs offer a systematic approach to achieving your aspirations.

FAQs

What is today's NAV of Nippon India Pharma Fund Direct Plan IDCW Payout?

NAV, or Net Asset Value, is the price of a single unit of a mutual fund. It is calculated by dividing the current value of holdings held by the mutual fund scheme at the end of the day by the total number of units issued. The NAV changes every day. The NAV of Nippon India Pharma Fund Direct Plan IDCW Payout on May 29 2024, is ₹154.4884